BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile


deCODE biostructures 

7869 NE Day Road West

Bainbridge Island  Washington  98110  U.S.A.
Phone: 206-780-8900 Fax: 206-780-8547


The integrated service offerings of deCODE chemistry and deCODE biostructures provide a unique and comprehensive approach to drug discovery and development outsourcing. deCODE biostructures services span from computer-aided design of expression-optimized synthetic gene constructs to protein expression and ligand bound co-crystal structure determination for purposes of structure based drug design. Capabilities of deCODE chemistry include lead discovery and optimization, development of scalable synthetic routes, custom synthesis of API and intermediates, cGMP production of materials for pre-clinical and clinical studies, and pre-formulation screening. The combined value is that deCODE provides a complete solution for discovering and developing optimized clinical candidates in a time efficient manner. Flexible business terms allow for tailored projects on a fee-for-service basis, or as part of a more substantial collaboration. deCODE’s facilities, located in Woodridge, IL and Bainbridge Island, WA, total over 150,000 sq ft. of multi-disciplinary laboratory space outfitted with state-of-the-art equipment and world-class scientists.

Last Updated: 08-01-2006

 Key Statistics

Ownership: Subsidiary

Web Site: deCODE biostructures

 Company News
Emerald BioStructures (Formerly deCODE biostructures) Publication in Nature Biotechnology Details Discovery of Allosteric Small Molecule Modulators of PDE4 with Reduced Side Effects 12/28/2009 8:39:53 AM
deCODE chemistry And deCODE biostructures: Fragments of Life – Enhancing Efficiency in Drug Discovery 7/24/2009 10:26:46 AM
deCODE biostructures And Mitsubishi Tanabe Pharma Corporation Initiate Fragments of Life(TM) Screening for Fragment Based Lead Discovery 4/16/2009 12:26:51 PM
deCODE chemistry & deCODE biostructures and UCB, Inc. (UCBJF.PK) Announce a Collaboration to Discover and Develop Novel Anti-Inflammatory Drugs 2/9/2009 12:55:32 PM
Families Of Spinal Muscular Atrophy, Invitrogen Corporation (IVGN), And deCODE biostructures And deCODE chemistry Release: Protein Linked to Spinal Muscular Atrophy Identified 10/9/2008 10:46:49 AM
deCODE biostructures Initiates Research Collaboration with Cubist Pharmaceuticals, Inc. (CBST) 2/18/2008 3:50:39 PM
deCODE biostructures Announces Fragments of LifeTM Milestone and Extension with InterMune, Inc. (ITMN) 1/30/2008 1:24:39 PM
deCODE biostructures and the Seattle Biomedical Research Institute to Collaborate 12/19/2007 10:37:47 AM
deCODE biostructures Announces Expansion of Collaboration with Replidyne, Inc. (RDYN) 11/16/2007 11:52:42 AM
Alex Kiselyov Joins deCODE biostructures as President; Lance Stewart Appointed President of deCODE biostructures 7/3/2007 5:42:37 PM